clinical trials

Chronic pain lasts longer for women than men, study finds – and the reason is biological

by

Finally, a Biological Explanation for Women’s Chronic Pain For generations, women’s reports of chronic pain have been dismissed, minimized, or attributed to emotional factors. Now, groundbreaking research published in Science Immunology is challenging these long-held biases, revealing a clear biological basis for why women often experience pain more intensely and for longer durations than men. … Read more

Novartis remibrutinib first therapy to achieve Phase III primary endpoint in chronic inducible urticaria (CIndU)

by

Novartis’ Remibrutinib Poised to Redefine Treatment for Chronic Inducible Urticaria In a significant advancement for patients battling chronic inducible urticaria (CIndU), Novartis has announced overwhelmingly positive results from its Phase III RemIND trial of remibrutinib. The oral medication has demonstrated the potential to become the first targeted therapy for this debilitating condition, offering hope to … Read more

AI Stethoscope: Improved Detection, But Limited Real-World Impact

by

The Future of Heart Health: AI Stethoscopes and the Challenges of Real-World Implementation Artificial intelligence is rapidly transforming healthcare, and one of the most promising applications lies in early disease detection. Recent trials with AI-enabled stethoscopes demonstrate significant potential for identifying heart failure, atrial fibrillation, and valvular heart disease – conditions where timely intervention is … Read more

Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP

by

FDA Delay for Disc Medicine’s Bitopertin: What’s Next for EPP Treatment? Watertown, Massachusetts – Disc Medicine (NASDAQ:IRON) faced a setback this week as the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for bitopertin, its investigational treatment for erythropoietic protoporphyria (EPP). While the news sent Disc Medicine’s stock price tumbling, the … Read more

Global Research Network: Authors & Affiliations

by

The Future of Clinical Trial Data: Towards Equity, Transparency, and Patient-Centricity The landscape of clinical research is undergoing a significant transformation, driven by ethical considerations, technological advancements, and a growing demand for greater transparency. Key figures like Ciara Staunton, Johanna M.C. Blom, and Luca Pani are at the forefront of this change, advocating for a … Read more

Scientist whose wife has incurable cancer creates large-scale breast cancer cell images to show ‘beauty in everything’

by

Turning Cancer Cells into Art: A New Frontier in Patient Empowerment and Scientific Communication A powerful exhibition in Greenwich, London, is challenging perceptions of cancer, transforming microscopic images of breast cancer cells into large-scale artworks. The exhibition, “Beyond The Ribbon,” hosted by the Pink Ribbon Foundation and running until February 14th, 2026, is the brainchild … Read more

New stem cell treatment may offer hope for Parkinson’s disease

by

Stem Cell Therapy: A New Dawn for Parkinson’s Disease and Beyond? For millions worldwide, Parkinson’s disease represents a relentless battle against debilitating motor and cognitive decline. But a groundbreaking clinical trial at Keck Medicine of USC offers a glimmer of hope – a novel stem cell therapy aiming not just to manage symptoms, but to … Read more

Base-Edited CAR T Cells: Remission in Leukemia & Transplant Progress

by

<h2>The Future of Cancer Treatment: Base-Edited CAR T-Cells and Beyond</h2> <p>A recent research highlight (dated January 30, 2026) signals a potential revolution in treating T cell acute lymphoblastic leukemia (T-ALL). Scientists are demonstrating success with base-edited CAR T-cells – a sophisticated form of immunotherapy. These aren’t just any CAR T-cells; they’re engineered to specifically target … Read more

Should Dopamine Remain a Target in Restless Legs Syndrome?

by

By Lisa Spear For years, dopamine agonists offered a lifeline to those suffering from Restless Legs Syndrome (RLS). But the honeymoon phase ended for many, replaced by a frustrating worsening of symptoms – a phenomenon known as RLS augmentation. Now, a shift in focus is underway, moving beyond simply boosting dopamine levels to a more … Read more

Discussing Personalized Treatment Options in Breast Cancer

by

The Future of Personalized Breast Cancer Treatment: Beyond One-Size-Fits-All For decades, breast cancer treatment followed relatively standardized protocols. But a shift is underway, driven by advancements in genomics, immunotherapy, and a growing understanding of the unique biological fingerprint of each tumor. Recent conversations with leading oncologists, like Dr. Tiffany Onger of the Cleveland Clinic, highlight … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: office@newsy-today.com

For contact, advertising, copyright, issues email: office@newsy-today.com